21/01/2026 — Staphyt, a leading contract research organization (CRO) and regulatory affairs consultant for agricultural experimentation and risk assessment, and GenoScreen, a pioneer and specialist in genomic and bioinformatics solutions, are pleased to announce the signing of a strategic collaboration agreement.
This alliance combines GenoScreen’s cutting-edge genomic technologies with Staphyt’s regulatory and experimental expertise into a single, unified offering. The objective is to provide the agro-industry and biosolutions sectors with a comprehensive solution covering the entire product development lifecycle, from scientific proof-of-concept to regulatory field validation.
Why this partnership matters
The development of microbial products, as biostimulants, and biocontrol solutions, as well as the assessment of their impact on soil and plant health, relies more than ever on accurate genomic analysis. These analyses are essential for providing solid scientific evidence and meeting European regulatory requirements, particularly regarding identification, traceability, safety and efficacy.
Without precise genomic characterization, ranging from the microorganism itself to its impact on soil microbial communities, securing market authorization is impossible. Industry players require robust, controlled data to guarantee the compliance and performance of their innovations.
A cooperation creating a complete value chain
Through this partnership:
GenoScreen expands its offering by leveraging Staphyt’s core competencies:
- Management of marketing authorization applications with competent authorities.
- Conducting efficacy trials in the field, greenhouses, or controlled experimental conditions.
- Performing laboratory studies (ecotoxicology, analytical chemistry, etc.) in accordance with regulatory requirements.
Staphyt strengthens its scientific capabilities through GenoScreen’s expertise:
- Microbial and regulatory genomics.
- Sequencing and bioinformatics analysis of microorganisms and plants.
- Development of genetic tools (specific qPCR, gene expression studies, soil microorganism impact studies).
"With this partnership, we aim to offer our clients an integrated experience where scientific rigor meets regulatory mastery. By uniting our know-how, GenoScreen and Staphyt are creating a unique continuum, from field trials to genomic data, entirely focused on regulatory proof. Our shared ambition is to support our clients in a complete, seamless, transparent, and expert manner. This is a concrete illustration of our vision: 'Redefine Service'."
Téo Fournier, Director of the Solutions and Services Department at GenoScreen.
"We are driven by the desire to offer an increasingly comprehensive 360° service to support our clients throughout the life of their projects. The collaboration between Staphyt and GenoScreen is a natural extension of our strategy to build partnerships in complementary fields that support innovation. This partnership stems from a growing client need to link genetic understanding with research and development studies in controlled conditions or open fields for regulatory data. Thus, we support the development of innovative solutions and provide the keys to meeting both current and future regulatory requirements."
Olivier Marchioro, CEO of Staphyt.
About Staphyt
Staphyt is a service provider and regulatory affairs consultant operating internationally in the agroscience, biocides, chemicals and pharmaceuticals sectors. Staphyt’s teams are located across Europe, Morocco, Brazil, and the United States. Deeply committed to innovation and client success, Staphyt helps navigate complex regulatory environments and generate high-quality data and registration dossiers to bring new products to market. Staphyt team expertise covers regulatory strategy, field trials, and laboratory studies, allowing for a global approach to product development and market access.
About GenoScreen
Based in Lille, France, GenoScreen is a biotechnology company specializing in microbial genomics and applied bioinformatics. For over 20 years, GenoScreen has supported players in agriculture, health, and nutrition in characterizing microorganisms, analyzing soil and plant microbiomes, and evaluating the impact of bio-inputs, including biostimulants and biocontrol solutions. True to its "Redefine Service" philosophy, the company places quality, expertise, and education at the heart of its approach to make genomic data accessible and actionable. Through a unique combination of research, technological innovation, and tailored support, GenoScreen has established itself as a leader in microbial genomics.
Press Contacts
- GenoScreen – Téo FOURNIER, Business Unit Director, This email address is being protected from spambots. You need JavaScript enabled to view it., +33 (0)3 62 26 37 84
- Staphyt – Héloïse STEPHAN, Marketing and Communication Manager, This email address is being protected from spambots. You need JavaScript enabled to view it., +33 (0)6 38 79 83 10